0001209191-17-047492.txt : 20170803 0001209191-17-047492.hdr.sgml : 20170803 20170803181129 ACCESSION NUMBER: 0001209191-17-047492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170801 FILED AS OF DATE: 20170803 DATE AS OF CHANGE: 20170803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUCAS ROGER C CENTRAL INDEX KEY: 0000902080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 171006362 MAIL ADDRESS: STREET 1: 41 EAST PLEASANT LAKE ROAD CITY: NORTH OAKS STATE: MN ZIP: 55127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-01 0 0001340652 ChemoCentryx, Inc. CCXI 0000902080 LUCAS ROGER C C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2017-08-01 4 S 0 2250 10.0742 D 93846 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.95 to $10.17 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Signature /s/ Susan M. Kanaya, as Attorney-in-Fact 2017-08-03